Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Inventory
Interpace Biosciences Inc
Inventory Peer Comparison
Competitive Inventory Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Interpace Biosciences Inc
OTC:IDXG
|
Inventory
$1.2m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Inventory
$145.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Inventory
$181m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
CVS Health Corp
NYSE:CVS
|
Inventory
$16.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Cigna Corp
NYSE:CI
|
Inventory
$4.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Inventory
$475m
|
CAGR 3-Years
4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
See Also
What is Interpace Biosciences Inc's Inventory?
Inventory
1.2m
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Inventory amounts to 1.2m USD.
What is Interpace Biosciences Inc's Inventory growth rate?
Inventory CAGR 3Y
-19%
Over the last year, the Inventory growth was -4%. The average annual Inventory growth rates for Interpace Biosciences Inc have been -19% over the past three years .